NCT06405529

Brief Summary

Introduction: Advances in knowledge have contributed to the increase in the number of patients who survive prolonged hospitalization in an Intensive Care Unit (ICU), and, among them, critically ill patients who develop acute respiratory failure and need for mechanical ventilation. These individuals have their mobility restricted to bed, and may suffer from pulmonary and systemic complications, such as ICU-Acquired Muscle Weakness, which increases the chances of resulting in reduced functional capacity or death. Early mobilization in the ICU has demonstrated benefits, but still with a low level of evidence. However, the type and intensity of exercise still need to be better defined, and previous protocols did not offer continuous monitoring from the ICU to the ward and subsequent outpatient rehabilitation for these patients, which is considered a limitation in some studies. Objective: To investigate the effects of an early and intensive hospital mobilization and post-hospital rehabilitation program on indicators of functionality, inflammation, cost-effectiveness, and mortality in critically ill patients undergoing invasive mechanical ventilation. Methods: This is a Blind Randomized Controlled Clinical Trial that will be conducted in the ICUs of the Hospital das Clinicas and the Emergency Unit of the Faculty of Medicine of Ribeirao Preto of the University of São Paulo. Patients of both sexes over 21 years of age who have been under invasive mechanical ventilation for at least 24 hours will be recruited. Patients will be randomized into the Intervention Group (IG), with 30 to 60 minutes of exercise per day, and the Control Group (CG), with 10 minutes of exercise per day, both with the same protocol and based on the ICU Mobility Scale - IMS, with continuity in the ward. After hospital discharge, participants will be allocated to the Guidance Group (GIor and GCor) and the Outpatient Rehabilitation Group (GIreab and GCreab), with functional exercise capacity as the main outcome, assessed by the six-minute walk test (6MWT). Volunteers will be monitored one, three, and six months after hospital discharge. The sample calculation was based on the results of the 6MWT , with a power of 80% for the assessments carried out at the proposing institution (n=206), and with a power of 90% for the multicenter project (n=275), considering a sample loss of 30%. The following will be evaluated: clinical parameters, severity indexes, functionality, lung function and mechanics, functional exercise capacity, mortality, inflammatory markers, energy expenditure, activities of daily living, quality of life, muscle assessment, adherence, barriers and facilitators and cost-effectiveness.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
206

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Jul 2024

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress72%
Jul 2024Jan 2027

First Submitted

Initial submission to the registry

January 7, 2024

Completed
4 months until next milestone

First Posted

Study publicly available on registry

May 8, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2025

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2027

Expected
Last Updated

May 8, 2024

Status Verified

May 1, 2024

Enrollment Period

7 months

First QC Date

January 7, 2024

Last Update Submit

May 6, 2024

Conditions

Keywords

Mechanical ventilationPhysiotherapyRespiratory functionFunctional capacityRehabilitationCost-effectiveness

Outcome Measures

Primary Outcomes (1)

  • Functional exercise capacity

    Assessed by the 6-minute walk test

    Through study completion, an average of 5 year

Secondary Outcomes (12)

  • Clinical parameters

    Through study completion, an average of 5 year

  • Clinical parameters

    Through study completion, an average of 5 year

  • Clinical parameters

    Through study completion, an average of 5 year

  • Clinical parameters

    Through study completion, an average of 5 year

  • Severity indexes

    Through study completion, an average of 5 year

  • +7 more secondary outcomes

Study Arms (4)

Control group

NO INTERVENTION

During hospitalization in the ICU and ward, this group will perform a maximum of 10 minutes of exercises of the casual care per day.

Intervention Group

EXPERIMENTAL

During hospitalization in the ICU and ward, this group will perform 30 to 60 minutes of exercises per day, according to the IMS scale and the intensive mobilization protocol.

Other: Early and intensive mobilization protocol at the ICU and Rehabilitation post-hospital discharge

Guidance Group

NO INTERVENTION

After hospital discharge, this group will not participate in any supervised exercise session, they will only be instructed by the therapists and receive the exercise booklet from the Rehabilitation Center.

Rehabilitation Group

EXPERIMENTAL

After hospital discharge, this group will participate in a supervised exercise program twice a week for 8 weeks at the Rehabilitation Center.

Other: Early and intensive mobilization protocol at the ICU and Rehabilitation post-hospital discharge

Interventions

During hospitalization in the ICU and ward, you will perform 30 to 60 minutes of exercises per day, according to the IMS scale. After hospital discharge, participation in a supervised exercise program twice a week for 8 weeks at the Rehabilitation Center - CER of the Hospital das Clínicas of the Faculty of Medicine of Ribeirão Preto.

Intervention GroupRehabilitation Group

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Both sexes
  • Age greater than or equal to 21 years
  • Be on invasive mechanical ventilation (IMV) for at least 48 hours
  • Sufficient cardiovascular stability for mobilization
  • Absence of bradyarrhythmia (\< 50 bpm);
  • Heart rate ≥ 150 bpm;
  • Most recent lactate measurement ≤ 4.0mmol/L;
  • Combined adrenaline/noradrenaline infusion rate ≤ 0.2mcg/Kg/min, OR if the adrenaline/noradrenaline infusion was increased by more than 25% in the last 6 hours;
  • Cardiac index ≥ 2.0L/min/m2; when evaluated
  • Respiratory stability sufficient for mobilization f) Respiratory rate ≤ 45rpm; g) FiO2 ≤ 0.6; h) PEEP ≤ 16 cmH2O; i) No need for NO (nitric oxide), prone position, neuromuscular blocker, ECMO (extracorporeal membrane oxygenation) or HFOV (high frequency ventilation).

You may not qualify if:

  • Dependent for ADLs in the month prior to ICU admission;
  • Diagnosed cognitive deficit;
  • Diagnosis OR suspicion of acute primary brain disease (TBI, stroke);
  • Diagnosis OR suspected spinal cord injury OR other neuromuscular disease that may result in prolonged or permanent muscle weakness (except muscle weakness acquired in the ICU);
  • Need OR instructions to remain in bed OR not to bear weight on the lower limbs bilaterally;
  • Life expectancy of less than 180 days due to acute or chronic clinical conditions;
  • Death considered inevitable due to current clinical condition or if the patient/clinical guardian is not committed to complete active treatment (e.g. brain death);
  • Inability to communicate in Portuguese;
  • Readmission to the ICU of the same hospital service;
  • Pregnant women;
  • Patients with a permanent pacemaker.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Respiratory Aspiration

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, PhD Physiotherapist

Study Record Dates

First Submitted

January 7, 2024

First Posted

May 8, 2024

Study Start

July 1, 2024

Primary Completion

January 31, 2025

Study Completion (Estimated)

January 31, 2027

Last Updated

May 8, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share